PSEN1 and Alzheimer disease: In contrast, the gain-of-function hypothesis states that most FAD mutations increase the production of longer, more aggregation-prone Aβ peptides, resulting in toxic oligomers that trigger Alzheimer’s disease (AD)10–12.